Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Scientific Reports|November 17, 2023
3D image scanning of gravel soil using in-situ X-ray computed tomographySatoshi Matsumura, Akihiko Kondo, Keita Nakamura, et al.
Annals of Biomedical Engineering|September 20, 2015
Development of a Novel Biodegradable Metallic Stent Based on Microgalvanic EffectJennifer Frattolin, Rajib Barua, Huseyin Aydin, et al.
International Journal of Sports Medicine|November 29, 2021
Functional Movement Screen Task Scores and Joint Range-of-motion: A Construct Validity StudyCesar A Hincapié, George A Tomlinson, Malinda Hapuarachchi, et al.
The Journal of Clinical Investigation|July 25, 2006
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutationShao H Yang, Margarita Meta, Xin Qiao, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activityQun Li, Tongmei Li, Keith W Woods, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitorsQun Li, Akiyo Claiborne, Tongmei Li, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitorsQun Li, Keith W Woods, Weibo Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
In vivo characterization of A-192411: a novel fungicidal lipopeptide (II)Jonathan A Meulbroek, Angela M Nilius, Qun Li, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitorsQun Li, Gary T Wang, Tongmei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft modelsDebra Ferguson, Luis E Rodriguez, Joann P Palma, et al.
Pageof 4